Effectiveness and Durability of the BNT162b2 KP.2 Vaccine Against COVID-19 Hospitalization and Emergency Department or Urgent Care Encounters in US Adults - Top-Institutions - MDSpire

Effectiveness and Durability of the BNT162b2 KP.2 Vaccine Against COVID-19 Hospitalization and Emergency Department or Urgent Care Encounters in US Adults

  • By

  • Sara Y Tartof

  • Timothy B Frankland

  • Jeff M Slezak

  • Bradley K Ackerson

  • Laura Puzniak

  • January 15, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Kaiser Permanente Southern California
    Kaiser Permanente Southern California

    Pasadena, California

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Vaccine Effectiveness Research
  • #2

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, Georgia

    Key Differentiators

    • Public Health
    • Infectious Diseases
    • Vaccine Policy and Surveillance
  • #3

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, Maryland

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Epidemiology
  • #4

    University of Washington School of Medicine
    University of Washington School of Medicine

    Seattle, Washington

    Key Differentiators

    • Infectious Diseases
    • Vaccine Development
    • Epidemiology
  • #5

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, Massachusetts

    Key Differentiators

    • Infectious Diseases
    • Clinical Research
    • Vaccine Immunology

Original Source(s)

Related Content